HER2-low breast cancer and response to neoadjuvant chemotherapy: a population-based cohort study. Baez-Navarro X, van Bockstal MR, Jager A, van Deurzen CHM, et al. Pathology 2024 Jan 18:S0031-3025(24)00007-2. doi: 10.1016/j.pathol.2023.

Read + Share

Amedeo Smart

Independent Medical Education

Baez-Navarro X, van Bockstal MR, Jager A, van Deurzen CHM, et al. HER2-low breast cancer and response to neoadjuvant chemotherapy: a population-based cohort study. Pathology 2024 Jan 18:S0031-3025(24)00007-2. doi: 10.1016/j.pathol.2023.
PMID: 38341307